Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Finasteride may help treat chronic CSC, improving vision.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride helps reduce priapism in sickle cell anemia patients.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

High doses of finasteride cause cell growth and tumors in mice.

Bidirectional barbed sutures are effective and can reduce surgery time, with a low infection rate and potential cost savings despite being more expensive.

The document explains how to identify different hair problems using a microscope.